Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical OutcomesSergey Shcherbinin,Cynthia D. Evans,Ming Lu,Scott W. Andersen,Michael J. Pontecorvo,Brian A. Willis,Ivelina Gueorguieva,Paula M. Hauck,Dawn A. Brooks,Mark A. Mintun,John R. SimsJAMA Neurology(2022)引用 32|浏览6暂无评分关键词amyloid reduction,donanemab treatment,tau pathologyAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要